ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,313Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 229

$632K Total Retail Price of All Prescriptions

Rank: 28 out of 229

829 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 829 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

10% of this provider’s 829 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 14,078 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LEVOTHYROXINE SODIUM 1,172 1,057 1 1
LISINOPRIL 1,118 981 2 2
OMEPRAZOLE 662 535 3 4
SIMVASTATIN 634 533 4 3
LOVASTATIN 575 528 5 11
HYDROCHLOROTHIAZIDE 482 448 6 9
AMLODIPINE BESYLATE 452 435 7 5
METFORMIN HCL 428 389 8 6
GABAPENTIN 319 281 9 10
ALENDRONATE SODIUM 314 282 10 14
HYDROCODONE-ACETAMINOPHEN 311 267 S3 11 7
ZOLPIDEM TARTRATE 301 241 12 20
LISINOPRIL-HYDROCHLOROTHIAZIDE 276 251 13 28
SERTRALINE HCL 256 246 14 22
LOSARTAN POTASSIUM 250 225 15 12
METOPROLOL SUCCINATE 247 220 16 16
ATENOLOL 238 212 17 19
FUROSEMIDE 233 202 18 8
GLIPIZIDE ER 229 190 19 81
FLUTICASONE PROPIONATE 225 189 20 23
TAMSULOSIN HCL 205 173 21 24
METOPROLOL TARTRATE 190 169 22 13
POTASSIUM CHLORIDE 174 169 23 18
DONEPEZIL HCL 166 166 24 29
RANITIDINE HCL 156 123 25 32
ALLOPURINOL 149 138 26 27
CRESTOR 145 138 27 30
FLUOXETINE HCL 137 104 28 41
CITALOPRAM HBR 135 101 29 21
IBUPROFEN 133 64 30 60
TERAZOSIN HCL 125 123 31 74
PANTOPRAZOLE SODIUM 116 102 32 33
WARFARIN SODIUM 100 100 33 17
FELODIPINE ER 100 100 33 61
MELOXICAM 99 82 35 45
PROAIR HFA 98 77 36 38
GLIPIZIDE XL 92 80 37 134
GEMFIBROZIL 91 86 38 62
TRAMADOL HCL 90 74 39 26
GLIPIZIDE 90 84 39 36
FINASTERIDE 90 89 39 55
OXYCODONE HCL-ACETAMINOPHEN 88 32 S2 42 73
OXYCODONE HCL 86 32 S2 43 37
VYTORIN 85 67 44 178
TRAZODONE HCL 84 81 45 34
FENOFIBRATE 79 76 46 68
JANUVIA 74 69 47 59
ATORVASTATIN CALCIUM 74 70 47 15
CLOPIDOGREL 73 73 49 44
OXYCODONE-ACETAMINOPHEN 73 47 S2 49 43
OXYBUTYNIN CHLORIDE ER 71 71 51 80
SPIRIVA 71 66 51 76
AMITRIPTYLINE HCL 67 34 R 53 66
DIGOXIN 65 65 54 92
LANTUS 64 54 55 40
NAMENDA 63 63 56 39
VENLAFAXINE HCL 60 46 57 145
TRIAMTERENE-HYDROCHLOROTHIAZID 60 58 57 223
AZITHROMYCIN 58 45 59 53
PLAVIX 57 57 60 72
TRIAMTERENE-HCTZ 57 56 60 51
CLONIDINE HCL 56 54 62 69
DOXAZOSIN MESYLATE 55 54 63 50
DILTIAZEM 24HR CD 54 53 64 89
GLYBURIDE 53 43 R 65 57
DILTIAZEM ER 51 41 66 123
NAPROXEN 51 43 66 94
METFORMIN HCL ER 51 49 66 77
PRAVASTATIN SODIUM 50 41 69 25
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 15, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.